Home Page

Anne Taylor, PhD'23, sat down with us to discuss her experience studying basic science at Vanderbilt and how it played a role in her career. Taylor is now a fellow at the Center for Opioid Research, Education & Outreach at the Auburn University Harrison College of Pharmacy. Read More

2024–25 Global Engagement Funding proposals are due by May 5, 2025. Read More

Meet David Baughman, the research program manager for the Vanderbilt Institute of Chemical Biology. Read More

Triple-negative breast cancer accounts for 10 percent of breast cancer cases in the U.S. annually. As T-cells that normally kill cancer cells often become exhausted and stop, Vanderbilt pharmacologists are seeking chemotherapy or targeted therapy approaches that can enhance the T-cell killing of cancer cells. Read More

“This transformative agreement allows Vanderbilt researchers to benefit from Nature’s tremendous influence and reach,” University Librarian Jon Shaw said. “Our research findings will reach global audiences immediately upon publication, speeding up scientific innovation and progress. This collaboration not only strengthens Vanderbilt’s reputation but will aid in attracting top faculty, students and partnerships to the university.” Read More

New research by Vanderbilt pharmacologists has uncovered inconsistencies in the active ingredient levels of a dietary supplement often referred to as corydalis. The work, published in Frontiers in Pharmacology, highlights concerns regarding the efficacy and authenticity of these widely used supplements. Read More

Ryan Hibbs, professor and chair of neurobiology at the University of California, San Diego, will present the Vanderbilt School of Medicine Basic Sciences Apex Lecture on March 27, 2025. Read More

Vanderbilt-affiliated authors may publish their original research articles APC-free in JAMA Network journals through a Creative Commons license. Twelve of the network’s journals—including JAMA Internal Medicine, JAMA Neurology and JAMA Oncology—are ranked in the top quartile of their respective subject areas. Read More

Diana Mitrea gave a talk for the Vanderbilt ASPIRE program’s Ph.D. Career Stories seminar series. She outlined her role as head of scientific and corporate communication at Dewpoint Therapeutics and her career transition from academia to industry. Read More

New research reveals that alcohol use can cause long-lasting changes in the brain’s dopamine system, even during abstinence. Vanderbilt researchers found that even after a month without alcohol, key regulators of dopamine activity remained altered, potentially increasing the risk of relapse. The study also challenges long-held assumptions about how gene expression relates to brain function, opening new doors for precision treatments in alcohol use disorder. Read More